Policies and actions reshaping the healthcare industry began pouring out of President Donald Trump’s White House nearly from ...

The medical technology company expects the new indication to increase sales in its transcatheter aortic valve replacement business with more patients becoming eligible for the treatment.

Linking the systems will allow clinicians to view glucose data captured by Libre glucose sensors within Epic’s systems.

Receiving FDA clearance would allow Medtronic to pair its pumps with a glucose monitor being developed for the company by ...

Executives said Thursday that the company has already laid off employees to help mitigate the effects of the Trump ...

Omniasecure, which was authorized for placement in the heart’s right ventricle, is the world’s smallest defibrillation lead, ...

Boston Scientific, Medtronic, Abbott and J&J unveiled new data for their PFA devices in tandem with the Heart Rhythm ...

In a letter to the FTC, three Democratic senators called for privacy standards for brain computer interface technology.

Inspectors found ICU Medical made multiple changes to infusion pumps without submitting premarket notifications.

While J&J, Abbott and Boston Scientific have all said the White House’s tariff policies will cost them hundreds of millions ...

The full-year tariff impact of 85 cents per share would have more than doubled without mitigation actions underway, ...

Stryker expects a $200 million hit to its 2025 earnings from tariffs, the latest medical device company to call out impacts ...